RK
Rajiv Kumar
About Rajiv Kumar
Data last updated:
Rajiv Kumar is a Director at U Square Lifescience Private Limited (since 2007), Director at Dorina Pharmaceutical Private Limited (since 2021) and Director at Mirus Pharma Private Limited (since 2009), and holds 2 more current directorships. The companies operate in Pharma, Paper and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹25.70 Cr; the largest is U Square Lifescience Private Limited at ₹24.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 U Square Lifescience Private Limited U24232GJ2007PTC050857 | Director | 17 May 2007 | 2007 | ₹24.98 Cr (FY 2024) | Active |
 Dorina Pharmaceutical Private Limited U24290GJ2021PTC126738 | Director | 26 Oct 2021 | 2021 | ₹41.5 Lakh (FY 2024) | Active |
| Mirus Pharma Private Limited U24230GJ2009PTC057075 | Director | 27 May 2009 | 2009 | ₹30.3 Lakh (FY 2024) | Active |
| Divinus Pharma Llp ACE-1356 | Designated Partner | 29 Nov 2023 | 2023 | Active | |
 U Square International Llp AAR-7953 | Designated Partner | 03 Feb 2020 | 2020 | Active |
Board colleagues of Rajiv Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Annapurna Rajiv Kumar | 01461522 | U Square Lifescience Private Limited , Dorina Pharmaceutical Private Limited and 2 more | Director |
| Dipak Jayantilal Modi | 10407603 | Divinus Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Kumar
Rajiv Kumar currently holds 5 directorships: U Square Lifescience Private Limited (Director, since 17 May 2007, revenue ₹24.98 Cr (FY 2024)); Dorina Pharmaceutical Private Limited (Director, since 26 Oct 2021, revenue ₹41.5 Lakh (FY 2024)); Mirus Pharma Private Limited (Director, since 27 May 2009, revenue ₹30.3 Lakh (FY 2024)); Divinus Pharma Llp (Designated Partner, since 29 Nov 2023); U Square International Llp (Designated Partner, since 03 Feb 2020).
Rajiv Kumar was first appointed on 17 May 2007 as Director at U Square Lifescience Private Limited. The most recent appointment on record is 29 Nov 2023 at Divinus Pharma Llp.
The 3 current companies of Rajiv Kumar that report revenue have a combined latest revenue of ₹25.70 Cr: U Square Lifescience Private Limited ₹24.98 Cr (FY 2024); Dorina Pharmaceutical Private Limited ₹41.5 Lakh (FY 2024); Mirus Pharma Private Limited ₹30.3 Lakh (FY 2024).
The current boards of Rajiv Kumar's companies include Annapurna Rajiv Kumar (U Square Lifescience Private Limited), Dipak Jayantilal Modi (Divinus Pharma Llp).